| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |